WHO ICTRP trial
Low dose Ferrous succinate sustained release tablets combined with Roxasta in…
ChiCTR2300072926 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300072926 |
|---|---|
| Public title | Low dose Ferrous succinate sustained release tablets combined with Roxasta in the treatment of renal anEmia in maintenance hEmodialysis patients |
| Scientific title | Low dose Ferrous succinate sustained release tablets combined with Roxasta in the treatment of renal anEmia in maintenance hEmodialysis patients |
| Primary sponsor | Peking University First Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | renal anemia |
| Interventions | low dose oral iron group:Oral ferrous succinate sustained-release tablets 200mg, elemental iron 70mg;high dose oral iron group:Oral ferrous succinate sustained-release tablets 600mg, elemental iron 210mg |
| Registration date | Jun 28, 2023 |
| Target size | low dose oral iron group:50;high dose oral iron group:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: